HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura S Stone Selected Research

Acetone

1/2021Disc degeneration spreads: long-term behavioural, histologic and radiologic consequences of a single-level disc injury in active and sedentary mice.
1/2020The geriatric pain experience in mice: intact cutaneous thresholds but altered responses to tonic and chronic pain.
9/2018Delayed onset of persistent discogenic axial and radiating pain after a single-level lumbar intervertebral disc injury in mice.
1/2018Low back pain and disc degeneration are decreased following chronic toll-like receptor 4 inhibition in a mouse model.
12/2015Behavioral signs of axial low back pain and motor impairment correlate with the severity of intervertebral disc degeneration in a mouse model.
12/2015Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta.
6/2013Alleviation of chronic neuropathic pain by environmental enrichment in mice well after the establishment of chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura S Stone Research Topics

Disease

29Pain (Aches)
10/2022 - 01/2000
14Hypersensitivity (Allergy)
01/2020 - 10/2010
11Low Back Pain (Lumbago)
06/2019 - 05/2011
9Chronic Pain
01/2020 - 05/2004
9Neuralgia (Stump Neuralgia)
01/2020 - 12/2003
8Intervertebral Disc Degeneration
09/2021 - 08/2011
7Inflammation (Inflammations)
11/2022 - 01/2007
4Hyperalgesia
12/2015 - 01/2007
3Neoplasms (Cancer)
01/2014 - 01/2000
2Back Pain (Backache)
01/2021 - 05/2018
2Musculoskeletal Pain
05/2018 - 01/2017
2Osteoarthritis
01/2017 - 02/2016
2Osteolysis
08/2015 - 01/2014
2Necrosis
06/2014 - 01/2014
2Spinal Cord Injuries (Spinal Cord Injury)
11/2009 - 01/2006
1Synovitis
01/2021
1Body Weight (Weight, Body)
01/2021
1Obesity
01/2021
1Parental Death
01/2020
1Bone Fractures (Bone Fracture)
12/2018
1Painful Neuropathy
09/2018
1Anhedonia
09/2018
1Osteoporosis
05/2018
1Arthritis (Polyarthritis)
05/2018
1Liver Diseases (Liver Disease)
01/2017
1Cognitive Dysfunction
01/2017
1Postoperative Pain
01/2017
1Dementia (Dementias)
01/2017
1Fibromyalgia (Fibrositis)
01/2017
1Neurobehavioral Manifestations
01/2017
1Neuroblastoma
12/2015
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
12/2015
1Osteogenesis Imperfecta (Lobstein Disease)
12/2015
1Neoplasm Metastasis (Metastasis)
01/2014
1Respiratory Insufficiency (Respiratory Failure)
01/2014
1Carcinoma (Carcinomatosis)
01/2014
1Breast Neoplasms (Breast Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

11Opioid Analgesics (Opioids)IBA
09/2018 - 01/2000
7AcetoneIBA
01/2021 - 06/2013
7Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2011
6salicylhydroxamic acid (SHAM)IBA
09/2018 - 10/2010
5Cysteine (L-Cysteine)FDA Link
01/2018 - 01/2011
5Morphine (MS Contin)FDA LinkGeneric
01/2017 - 01/2000
4Nerve Growth Factor (NGF)IBA
05/2018 - 01/2014
4AgmatineIBA
11/2009 - 01/2006
3CytokinesIBA
10/2022 - 01/2014
3Pain-FreeIBA
05/2019 - 06/2015
3Diphosphonates (Bisphosphonates)IBA
05/2018 - 01/2014
3Analgesics (Analgesic Drugs)IBA
12/2015 - 05/2004
3N-Methylaspartate (NMDA)IBA
04/2013 - 01/2007
2ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
10/2022 - 01/2018
2Toll-Like Receptor 4IBA
10/2022 - 01/2018
2Messenger RNA (mRNA)IBA
09/2021 - 01/2020
2Biological ProductsIBA
01/2021 - 06/2019
2Opioid Receptors (Opioid Receptor)IBA
09/2018 - 04/2009
2Pamidronate (Aredia)FDA LinkGeneric
01/2017 - 01/2014
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2017 - 06/2011
2Biomarkers (Surrogate Marker)IBA
01/2016 - 06/2011
2Sirolimus (Rapamycin)FDA Link
08/2015 - 01/2014
2Synaptotagmin IIIBA
01/2015 - 04/2013
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 08/2011
2Arginine (L-Arginine)FDA Link
11/2009 - 01/2006
2moxonidine (Moxon)IBA
12/2003 - 01/2000
1MineralsIBA
11/2022
1polyetheretherketoneIBA
11/2022
1Carboxylic AcidsIBA
02/2021
1SugarsIBA
01/2021
1Ion Channels (Ion Channel)IBA
01/2020
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
01/2020
1reparixinIBA
05/2019
1Interleukin-8 (Interleukin 8)IBA
05/2019
1TitaniumIBA
12/2018
1Sucrose (Saccharose)IBA
09/2018
1AntibodiesIBA
05/2018
1HemopexinIBA
10/2017
1Cystatin CIBA
10/2017
1S-Adenosylmethionine (Ademetionine)IBA
01/2017
1Pregabalin (Lyrica)FDA Link
01/2017
1CalciumIBA
12/2015
1LigandsIBA
12/2015
1alpha2 Subunit Collagen Type IIBA
12/2015
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
12/2015
1NeuropeptidesIBA
12/2015
1Collagen Type I (Type I Collagen)IBA
12/2015
1Pharmaceutical PreparationsIBA
08/2015
1CytosineIBA
01/2015
1Neuropeptide YIBA
08/2014
1Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2014
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2014
1Formaldehyde (Formol)FDA Link
05/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014

Therapy/Procedure

4Therapeutics
05/2018 - 05/2004
2Ovariectomy (Oophorectomy)
05/2018 - 01/2017
2Injections
01/2014 - 05/2011
2Analgesia
10/2009 - 08/2003
1Punctures
09/2018
1Spinal Fusion (Spondylosyndesis)
01/2017
1Oral Administration
01/2017
1Aftercare (After-Treatment)
06/2015